
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
SP-D CRISPR/Cas9 KO Plasmid (m) | sc-422903 | 20 µg | $397.00 |
Sftpd encodes surfactant protein D (SP-D), a secreted collectin produced primarily by alveolar type II cells and Clara cells that contributes to pulmonary surfactant homeostasis and innate immune defense at mucosal surfaces. SP-D recognizes carbohydrate patterns on microbes and apoptotic cells, promoting opsonization, agglutination, and modulation of macrophage and neutrophil activity through lectin-dependent interactions. Functionally, SP-D intersects with pathways controlling alveolar proteostasis, inflammatory cytokine signaling, and oxidative stress responses that shape airway barrier integrity. Altered Sftpd/SP-D activity is linked to dysregulated lung inflammation and remodeling, making it relevant for studying mechanisms of acute lung injury, asthma- and COPD-like phenotypes, and susceptibility to respiratory infection in mouse models.
SP-D CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Sftpd gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Sftpd together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Sftpd open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish SP-D protein expression.
This CRISPR knockout system enables efficient generation of Sftpd-deficient cell models for investigation of SP-D signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.